$0.95 -0.03 (-2.89%)
enVVeno Medical Corporation Common Stock (NVNO)
enVVeno Medical Corporation (NVNO) is a medical device company focused on developing and commercializing minimally invasive platelet-rich plasma (PRP) therapies for venous and chronic wound conditions. The company aims to provide innovative solutions for vascular and wound care treatments through its proprietary technologies.
Company News
Chronic Venous Insufficiency Market to Increase at a CAGR of 9.4% During the Forecast Period (2025–2034) Due to the Launch of Emerging Therapies and Chronic Venous Insufficiency Medical Devices | DelveInsight
The chronic venous insufficiency market is projected to grow from $2.1 billion in 2024 to a larger market by 2034, driven by emerging therapies, medical devices, and increasing prevalence of the condition in aging populations.
enVVeno (NVNO) Plans to Expedite enVVe Development for CVI
enVVeno (NVNO) notes that its capital position is now strong enough to begin the enVVe pivotal study.